COVID vaccines saved nearly 20 million lives in 1st year, scientists say
Researchers estimate that COVID-19 vaccine shots prevented 1.9 million deaths in the United States during the first year they became available....
Researchers estimate that COVID-19 vaccine shots prevented 1.9 million deaths in the United States during the first year they became available....
The challenges of the pandemic may have given the clinical research profession the gift of perspective that will positively affect the outlook on our industry’s collective future....
The Centers for Disease Control and Prevention authorized the COVID-19 vaccine for kids under five and UW Health experts say they’re ready to start rolling out vaccinations in Wisconsin....
A research team led by University of Wisconsin–Madison virologist Yoshihiro Kawaoka and colleagues in Japan show that the BA.2 subvariant of omicron is similar to BA.1 in both the severity of illness it causes and in its ability to cause infection....
UW Health CEO Dr. Alan Kaplan weighed in on the lessons of the COVID-19 pandemic, his health system’s efforts to expand care and how mergers in the state could affect them during a Wisconsin Health News Newsmaker event Thursday....
Moderna announced Thursday morning that it's asking the FDA to approve its COVID vaccine for kids under 6 years old. If authorized for emergency use, it would become the first eligible vaccine for kids younger than 5....
Early clinical trials suggest vaccines that activate T cells work better and faster and may protect people with weakened immune systems....
We must apply lessons learned in the development of the COVID-19 vaccines, including community engagement strategies and innovative clinical trial design, to longstanding public health challenges such as TB....
In the arena of clinical research, gender equity accelerates research excellence: we need multiple perspectives and all the brain power we can muster to maximize research productivity and quality....
Moderna announced that positive safety and efficacy results from its 'KidCOVE' COVID-19 vaccine study open the door for the company to request emergency use authorization from the FDA to vaccinate children under 6 years of age....